These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34808497)

  • 21. The murine DCs transfected with DNA-plasmid encoding CCR9 demonstrate the increased migration to CCL25 and thymic cells in vitro and to the thymus in vivo.
    Tereshchenko V; Bulygin A; Zavodskii R; Maksyutov A; Kurilin V; Fisher M; Semenyuk N; Aladev S; Sennikov S
    Cytokine; 2021 Jun; 142():155473. PubMed ID: 33647585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CCR9-CCL25 interaction suppresses apoptosis of lung cancer cells by activating the PI3K/Akt pathway.
    Li B; Wang Z; Zhong Y; Lan J; Li X; Lin H
    Med Oncol; 2015 Mar; 32(3):66. PubMed ID: 25691296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesenchymal stem cells and their chondrogenic differentiated and dedifferentiated progeny express chemokine receptor CCR9 and chemotactically migrate toward CCL25 or serum.
    Ullah M; Eucker J; Sittinger M; Ringe J
    Stem Cell Res Ther; 2013 Aug; 4(4):99. PubMed ID: 23958031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and functional role of CCR9 in prostate cancer cell migration and invasion.
    Singh S; Singh UP; Stiles JK; Grizzle WE; Lillard JW
    Clin Cancer Res; 2004 Dec; 10(24):8743-50. PubMed ID: 15623660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine.
    Amersi FF; Terando AM; Goto Y; Scolyer RA; Thompson JF; Tran AN; Faries MB; Morton DL; Hoon DS
    Clin Cancer Res; 2008 Feb; 14(3):638-45. PubMed ID: 18245522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of the CCL25-CCR9 axis in beta-cell function: potential for therapeutic intervention in type 2 diabetes.
    Atanes P; Lee V; Huang GC; Persaud SJ
    Metabolism; 2020 Dec; 113():154394. PubMed ID: 33058852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ezrin is a key molecule in the metastasis of MOLT4 cells induced by CCL25/CCR9.
    Zhou B; Leng J; Hu M; Zhang L; Wang Z; Liu D; Tong X; Yu B; Hu Y; Deng C; Liu Y; Zhang Q
    Leuk Res; 2010 Jun; 34(6):769-76. PubMed ID: 20036004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCL25/CCR9 interactions regulate large intestinal inflammation in a murine model of acute colitis.
    Wurbel MA; McIntire MG; Dwyer P; Fiebiger E
    PLoS One; 2011 Jan; 6(1):e16442. PubMed ID: 21283540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCR9 mediates PI3K/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide.
    Sharma PK; Singh R; Novakovic KR; Eaton JW; Grizzle WE; Singh S
    Int J Cancer; 2010 Nov; 127(9):2020-30. PubMed ID: 20127861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemokine (C-C motif) ligand 25 expressed by trophoblast cells and leukocytes bearing its receptor Ccr9: An alliance during embryo implantation?
    Weingrill RB; Hoshida MS; Martinhago CD; Correa-Silva S; Cardoso E; Palmeira P; Marinho CRF; Bevilacqua E
    Am J Reprod Immunol; 2018 Jan; 79(1):. PubMed ID: 29154408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CC chemokine ligand 25 enhances resistance to apoptosis in CD4+ T cells from patients with T-cell lineage acute and chronic lymphocytic leukemia by means of livin activation.
    Qiuping Z; Jei X; Youxin J; Wei J; Chun L; Jin W; Qun W; Yan L; Chunsong H; Mingzhen Y; Qingping G; Kejian Z; Zhimin S; Qun L; Junyan L; Jinquan T
    Cancer Res; 2004 Oct; 64(20):7579-87. PubMed ID: 15492285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CCR9 overexpression promotes T-ALL progression by enhancing cholesterol biosynthesis.
    Jamal M; Lei Y; He H; Zeng X; Bangash HI; Xiao D; Shao L; Zhou F; Zhang Q
    Front Pharmacol; 2023; 14():1257289. PubMed ID: 37745085
    [No Abstract]   [Full Text] [Related]  

  • 33. CCL25 promotes the migration and invasion of non-small cell lung cancer cells by regulating VEGF and MMPs in a CCR9-dependent manner.
    Niu Y; Tang D; Fan L; Gao W; Lin H
    Exp Ther Med; 2020 Jun; 19(6):3571-3580. PubMed ID: 32346420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin-converting enzyme inhibition down-regulates the pro-atherogenic chemokine receptor 9 (CCR9)-chemokine ligand 25 (CCL25) axis.
    Abd Alla J; Langer A; Elzahwy SS; Arman-Kalcek G; Streichert T; Quitterer U
    J Biol Chem; 2010 Jul; 285(30):23496-505. PubMed ID: 20504763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CCL25 chemokine-guided stem cell attraction: an assessment of possible benefits and risks.
    Spinnen J; Ringe J; Sittinger M
    Regen Med; 2018 Oct; 13(7):833-844. PubMed ID: 30284497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Granulocyte-macrophage colony stimulating factor blockade promotes ccr9(+) lymphocyte expansion in Nod2 deficient mice.
    Samson CM; Jurickova I; Molden E; Schreiner W; Colliver J; Bonkowski E; Han X; Trapnell BC; Denson LA
    Inflamm Bowel Dis; 2011 Dec; 17(12):2443-55. PubMed ID: 21381154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased circulating CXCR3 + CCR9+T helper cells are associated with elevated levels of their ligands CXCL10 and CCL25 in the salivary gland of patients with Sjögren's syndrome to facilitate their concerted migration.
    Blokland SLM; Kislat A; Homey B; Smithson GM; Kruize AA; Radstake TRDJ; van Roon JAG
    Scand J Immunol; 2020 Mar; 91(3):e12852. PubMed ID: 31733111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracellular expression profile and clinical significance of the CCR9-CCL25 chemokine receptor complex in nasopharyngeal carcinoma.
    Ye LF; Huang J; Zhang LP; Chen Z
    J Laryngol Otol; 2015 Oct; 129(10):1013-9. PubMed ID: 26279399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD33
    Sun Y; Shao J; Jiang F; Wang Y; Yan Q; Yu N; Zhang J; Zhang J; Li M; He Y
    Am J Reprod Immunol; 2019 Jan; 81(1):e13067. PubMed ID: 30375700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CCR9 Is a Key Regulator of Early Phases of Allergic Airway Inflammation.
    López-Pacheco C; Soldevila G; Du Pont G; Hernández-Pando R; García-Zepeda EA
    Mediators Inflamm; 2016; 2016():3635809. PubMed ID: 27795621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.